The aim of EACTAIC is to be a forum in Europe for international scientific discussions and exchange of ideas in the field of cardiothoracic anaesthesia and related topics and to promote education and development in this field. Join us for the European Association of Cardiothoracic Anaesthesiology and Intensive Care (EACTAIC) congress, 5th-7th October 2022, in Vilnius Lithuania.
European Association of Cardiothoracic Anaesthesiology and Intensive Care (EACTAIC) congress 2022
The EACTAIC Annual Congress is recognised as a leading international forum for the exchange of knowledge in the fields of cardiovascular and thoracic anaesthesia. The inaugural meeting took place in Cambridge in 1986. Subsequently, the meeting has been organised in a large number of cities around Europe. Most recently, the meetings have been held in Vienna (2011), Amsterdam (2012), Barcelona (2013), Florence (2014), Gothenburg (2015), Basel (2016), Berlin (2017), Manchester (2018), Ghent (2019), Grenoble (2020, Online edition due to COVID-19 pandemic), Joint EACTAIC-ICCVA (2021, Online edition). The 2022 EACTAIC Annual Congress will be held in Vilnius, Lithuania on October 5th-7th, 2022.
Each event attracts the region’s key leaders in these fields. The Annual Meeting offers a unique platform to connect with all the aspects of our sub-speciality of cardiothoracic and vascular anaesthesia and intensive care through educational symposia, round tables, lectures, networking and social activities. By doing so, the Annual Meeting is valuable to both professional colleagues and to our industry partners. We aim to provide the environment in which innovation and collaboration can take place, through the sharing of the latest knowledge, information, creative thinking and differing global perspectives.
More content available within our dedicated Learning Zones and Speciality Hubs
Fibrinogen Deficiency in Bleeding Learning Zone
Fibrinogen is an essential coagulation factor in the blood clotting cascade. The importance for fibrinogen in normal haemostasis is highlighted in patients of inherited fibrinogen deficiencies who display coagulopathies such as excessive bleeding and thrombolytic events.
Assorted resources on conditions connected to Cardiology.
Antiplatelet therapy in ACS: Choices and Controversies
Acute coronary syndrome (ACS) represents a leading cause of mortality and morbidity worldwide. Antiplatelet therapy is a cornerstone of ACS management.